Professor Dirk De Ridder investigates the effect of low dose Ketamine and High Definition Transcranial Infraslow Pink Noise Stimulation (HD-tIPNS) on tinnitus loudness and severity in a Phase 1/2 clinical trial.
24 trial subjects with chronic tinnitus will receive treatment at the University of Otago Dunedin School of Medicine, in New Zealand. The treatment will be delivered twice, with 10 days between sessions.
Key Inclusion criteria: Adults aged between 18-70 years with constant subjective tinnitus and a grade of 3 or higher on the tinnitus questionnaire.
Source:
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381021
24 trial subjects with chronic tinnitus will receive treatment at the University of Otago Dunedin School of Medicine, in New Zealand. The treatment will be delivered twice, with 10 days between sessions.
Key Inclusion criteria: Adults aged between 18-70 years with constant subjective tinnitus and a grade of 3 or higher on the tinnitus questionnaire.
Source:
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381021